Alkermes (ALKS) Shares Outstanding (Diluted) (2010 - 2026)
Alkermes (ALKS) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 833.33 Mn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 173.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.48 Mn |
| Mar 31, 2026 | 166.20 Mn |
| Dec 31, 2025 | 168.74 Mn |
| Sep 30, 2025 | 168.51 Mn |
| Jun 30, 2025 | 168.36 Mn |
| Mar 31, 2025 | 168.74 Mn |
| Dec 31, 2024 | 169.20 Mn |
| Sep 30, 2024 | 167.03 Mn |
| Jun 30, 2024 | 170.98 Mn |
| Mar 31, 2024 | 172.98 Mn |
| Dec 31, 2023 | 169.73 Mn |
| Sep 30, 2023 | 171.90 Mn |
| Jun 30, 2023 | 171.55 Mn |
| Mar 31, 2023 | 165.09 Mn |
| Dec 31, 2022 | 163.54 Mn |
| Sep 30, 2022 | 164.28 Mn |
| Jun 30, 2022 | 163.84 Mn |
| Mar 31, 2022 | 162.48 Mn |
| Dec 31, 2021 | 160.94 Mn |
| Sep 30, 2021 | 161.46 Mn |